Literature DB >> 20115927

Hypothesis: the "metabolic memory", the new challenge of diabetes.

Antonio Ceriello1.   

Abstract

Large randomized studies have established that early intensive glycaemic control reduces the risk of diabetic complications, both micro and macrovascular. However, epidemiological and prospective data support a long-term influence of early metabolic control on clinical outcomes. This phenomenon has recently been defined as "metabolic memory". Potential mechanisms for propagating this "memory" are the non-enzymatic glycation of cellular proteins and lipids, and an excess of cellular reactive oxygen and nitrogen species, in particular originated at the level of glycated-mitochondrial proteins, perhaps acting in concert with one another to maintain stress signaling. Furthermore, the emergence of this "metabolic memory" suggests the need of a very early aggressive treatment aiming to "normalize" the metabolic control and the addition of agents which reduce cellular reactive species and glycation in addition to normalizing glucose levels in diabetic patients in order to minimize long-term diabetic complications. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20115927     DOI: 10.1016/S0168-8227(09)70002-6

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  44 in total

Review 1.  Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.

Authors:  Toni Terry; Kalyani Raravikar; Nalurporn Chokrungvaranon; Peter D Reaven
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

Review 2.  Epigenetic mechanisms in diabetic vascular complications.

Authors:  Marpadga A Reddy; Rama Natarajan
Journal:  Cardiovasc Res       Date:  2011-01-25       Impact factor: 10.787

Review 3.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

4.  Traditional Chinese medicine formula Qing Huo Yi Hao as superoxide anion scavenger in high glucose-treated endothelial cells.

Authors:  Qiong Xu; Bin Zhang; Xiao-mu Li; Xin Gao
Journal:  Acta Pharmacol Sin       Date:  2012-03-19       Impact factor: 6.150

Review 5.  Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations.

Authors:  Lixia Xu; Rama Natarajan; Zhen Chen
Journal:  Curr Diab Rep       Date:  2019-02-07       Impact factor: 4.810

6.  Gestational diabetes induces alterations of sirtuins in fetal endothelial cells.

Authors:  Juan Gui; Arne Potthast; Anne Rohrbach; Katja Borns; Anibh M Das; Frauke von Versen-Höynck
Journal:  Pediatr Res       Date:  2015-12-30       Impact factor: 3.756

7.  Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair.

Authors:  Parul Mehra; Yiru Guo; Yibing Nong; Pawel Lorkiewicz; Marjan Nasr; Qianhong Li; Senthilkumar Muthusamy; James A Bradley; Aruni Bhatnagar; Marcin Wysoczynski; Roberto Bolli; Bradford G Hill
Journal:  Basic Res Cardiol       Date:  2018-10-23       Impact factor: 17.165

8.  Imbalance between HDAC and HAT activities drives aberrant STAT1/MyD88 expression in macrophages from type 1 diabetic mice.

Authors:  Luciano Ribeiro Filgueiras; Stephanie L Brandt; Theresa Raquel de Oliveira Ramalho; Sonia Jancar; C Henrique Serezani
Journal:  J Diabetes Complications       Date:  2016-08-07       Impact factor: 2.852

9.  A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  Carlos Lorenzo; Lynne E Wagenknecht; Anthony J G Hanley; Marian J Rewers; Andrew J Karter; Steven M Haffner
Journal:  Diabetes Care       Date:  2010-06-23       Impact factor: 19.112

10.  Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: The Diabetes & Aging Study.

Authors:  Neda Laiteerapong; Andrew J Karter; Howard H Moffet; Jennifer M Cooper; Robert D Gibbons; Jennifer Y Liu; Yue Gao; Elbert S Huang
Journal:  J Diabetes Complications       Date:  2016-07-26       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.